Oct 27, 2021 / 02:30AM GMT
Operator
Good morning, ladies and gentlemen. Welcome to the Dr. Lal PathLabs Q2 FY '22 Earnings Conference Call. (Operator Instructions)
Please note that this conference is being recorded. I now hand the conference over to Mr. Siddharth Rangnekar of CDR India. Thank you, and over to you, sir.
Siddharth Rangnekar - Citigate Dewe Rogerson Communications Private Limited - IR Manager
Thank you. Good morning, everyone, and welcome to Dr. Lal PathLabs Quarter 2 and H1 FY '22 Earnings Conference Call. Today, we are joined by senior members of the management team, including Honorary Brigadier, Dr. Arvind Lal, Executive Chairman; Dr. Om Prakash Manchanda, Managing Director; Mr. Bharath Uppiliappan, CEO; and Mr. Ved Prakash Goel, CFO; along with Mr. Rajat Kalra, Company Secretary and Head of Investor Relations. Also joining us today is Dr. Sanjay Arora, Founder of Suburban Diagnostics.
Let me lead our standard disclaimer over here. Some of the statements made on today's call could be forward-looking in nature, and the actual results could vary from these forward
Q2 2022 Dr. Lal PathLabs Ltd Earnings Call Transcript
Oct 27, 2021
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers